Applied computer scientists at the University of Bamberg are currently developing an AI medical companion that will help doctors in recognising and diagnosing types of cancer and pain.
Why do blood clots develop in the first place—and why do they tend to recur? LMU researcher Konstantin Stark believes that the answers lie in the immune system.
SciFiMed is a multi-disciplinary project that combines fundamental immunological research with novel nanomaterial biosensor development translated into proof-of-principle diagnostics. International experts as well as biotechnology enterprises and health institutions are involved in the project.
Scientists at the University of Bayreuth are conducting cutting-edge, interdisciplinary research in biofabrication. The high-tech processes they are developing open up new possibilities for biomedical therapies.
Researchers at FAU are working across disciplines and with industry partners to develop cutting-edge AI applications that could revolutionize medicine and healthcare.
At RCI, the Regensburg Center for Interventional Immunology, international research groups develop immunotherapies and cellular therapies in order to help treating patients suffering from tumors, chronic inflammation or autoimmunity.
From junior research group leader to full professor and spokesperson of the Research Center for Infectious Diseases (ZINF) at the University of Würzburg. This is the scientific career path of Cynthia Sharma.
The cells of a certain tumour type, called neuroblastoma, divide very rapidly. This rapid division can have potentially fatal consequences for them. A new study shows how neuroblastoma cells deal with this dilemma.
In part of a recent human study led by the Technical University of Munich (TUM), it was found that after eating a curry dish containing pepper, piperine - an alkaloid responsible for the pungency of pepper - was present in the milk of breastfeeding women. The findings help decipher mechanisms that shape our food preferences from infancy.
Prof. Dr Othmar Moser, head of the division Exercise Physiology & Metabolism at the University of Bayreuth, has been awarded the 2021 Langerhans Prize of the Austrian Diabetes Society (OEDG). On 20 November 2021, he accepted the prize of € 10,000 at the OEDG annual general meeting in Salzburg. Recently, he and his research team studied the immune response of people with diabetes after COVID-19 vaccination. The results underline the importance of booster vaccinations for older people with diabetes, especially in the case of impaired kidney function.
This website uses cookies and the Matomo web analysis tool. By continuing to browse you agree to our use of cookies. Change your settings here. More information.
